Find insight on Sartorius, Praram 9 Hospital and more in the latest Market Talks covering the Health Care sector.

Westbourne River Partners letter to Biotest AG with respect to the delisting offer made by Grifols SA to shareholders of Biotest.

MADRID (Reuters) -Shares in Spanish pharmaceutical company Grifols rose on Wednesday after Canadian fund Brookfield said it was talking with shareholders, following a report from website El ...

Hamilton Mayor Andrea Horwath says she’s disappointed that a private plasma collection centre has opened in the city’s east ...

Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to identify early biological signals of Parkinson’s ...

The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almost $6 ...

The market for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) was valued USD 968 Million in 2017 which is anticipated to reach USD 2,020.6 Million by 2030.

Neuropathic pain, defined as pain caused by a lesion or disease of the somatosensory nervous system, does not act as a signal to warn the body of damage as acute pain does, and thus it does not have a ...

European equities traded in the US as American depositary receipts were rising late Monday morning, up 1.19% to 1,327.75 on the S&P Europe Select ADR Index. From continental Europe, the gainers were ...

A new smart insole system that monitors how people walk in real time could help users improve posture and provide early warnings for conditions from plantar fasciitis to Parkinson's disease.

As per Vantage Market Research, the Global Plasma Therapy Market has steadily grown over the years due to its potential to ...